Cigna Group (NYSE:CI) Receives $330.36 Consensus PT from Analysts

Cigna Group (NYSE:CI) has been assigned a consensus rating of “Moderate Buy” from the twenty-three analysts that are currently covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $330.3636.

A number of equities analysts have recently weighed in on the stock. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, January 24th. Wolfe Research decreased their price objective on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, October 15th. Morgan Stanley reaffirmed an “overweight” rating and issued a $355.00 price objective on shares of Cigna Group in a research note on Friday, October 31st. Cantor Fitzgerald lowered their price objective on shares of Cigna Group from $365.00 to $325.00 in a research report on Friday, October 31st. Finally, Truist Financial lifted their target price on shares of Cigna Group from $310.00 to $320.00 and gave the stock a “buy” rating in a report on Monday, January 5th.

Cigna Group Trading Down 0.4%

Shares of NYSE:CI opened at $271.18 on Friday. The business’s 50 day moving average price is $274.66 and its 200-day moving average price is $284.85. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The firm has a market capitalization of $72.44 billion, a price-to-earnings ratio of 11.96, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the previous year, the company posted $7.51 EPS. Cigna Group’s revenue was up 9.5% compared to the same quarter last year. On average, equities research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO David Cordani acquired 4,134 shares of the firm’s stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Cigna Group

Several institutional investors have recently made changes to their positions in CI. Pathway Financial Advisers LLC boosted its holdings in Cigna Group by 2.3% in the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock valued at $496,000 after purchasing an additional 34 shares during the last quarter. Armstrong Advisory Group Inc. lifted its position in shares of Cigna Group by 17.7% during the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after buying an additional 34 shares in the last quarter. HM Payson & Co. increased its stake in shares of Cigna Group by 0.9% during the third quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after purchasing an additional 35 shares in the last quarter. Carr Financial Group Corp raised its holdings in shares of Cigna Group by 5.3% during the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after acquiring an additional 36 shares during the last quarter. Finally, Natural Investments LLC boosted its stake in Cigna Group by 2.0% during the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock worth $531,000 after purchasing an additional 36 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.